Page last updated: 2024-11-02

1,2-cyclohexanediamine and Pulmonary Embolism

1,2-cyclohexanediamine has been researched along with Pulmonary Embolism in 1 studies

1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation

Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.

Research Excerpts

ExcerptRelevanceReference
"We aimed to assess pulmonary embolism-related mortality and time trends for the DACH countries based on data from the WHO Mortality Database."1.72[Trends in mortality related to pulmonary embolism in the DACH countries]. ( Barco, S; Hobohm, L; Johner, F; Keller, K; Konstantinides, SV; Kucher, N; Mahmoudpour, SH; Münzel, T; Sebastian, T; Valerio, L; Vatsakis, G, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hobohm, L1
Sebastian, T1
Valerio, L1
Mahmoudpour, SH1
Vatsakis, G1
Johner, F1
Keller, K1
Münzel, T1
Kucher, N1
Konstantinides, SV1
Barco, S1

Other Studies

1 other study available for 1,2-cyclohexanediamine and Pulmonary Embolism

ArticleYear
[Trends in mortality related to pulmonary embolism in the DACH countries].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2022, Volume: 117, Issue:6

    Topics: Austria; Cyclohexylamines; Female; Germany; Humans; Male; Pulmonary Embolism; Thrombosis

2022